TransCode Therapeutics Publishes Open Letter Outlining Company’s Progress and Objectives
Go back to TransCode Therapeutics Publishes Open Letter Outlining Company’s Progress and Objectives| (NASDAQ: RNAZ) | Delayed: 3.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.96 | 52 Week High | $ | |||
| Open | $3.96 | 52 Week Low | $ | |||
| Day High | $3.96 | P/E | N/A | |||
| Day Low | $3.96 | EPS | $ | |||
| Volume | 3,756 | |||||

